Indolent T-cell lymphoproliferative disorder of the stomach successfully treated by radiotherapy.
ITLPDGL
gastric cancer
involved field radiotherapy
lymphoproliferative disorder
treatment
Journal
Journal of clinical and experimental hematopathology : JCEH
ISSN: 1880-9952
Titre abrégé: J Clin Exp Hematop
Pays: Japan
ID NLM: 101141257
Informations de publication
Date de publication:
2020
2020
Historique:
entrez:
1
4
2020
pubmed:
1
4
2020
medline:
14
1
2021
Statut:
ppublish
Résumé
Successful treatment of indolent T-cell lymphoproliferative disorder of the gastrointestinal tract (ITLPDGI) by chemotherapy is rare and watchful waiting is often performed for asymptomatic patients. We report a case of ITLPDGI successfully treated by involved field radiotherapy (IFRT). The patient presented with slow ITLPDGI localised to the stomach with mild symptoms. IFRT (30 Gy/20f) was administered, after which endoscopy revealed resolution of lesions and blood vessel appearance, and absence of proliferating abnormal lymphocytes was confirmed by biopsy. The patient remains lymphoma-free 1 year post-treatment. Although long-term follow-up and additional cases are essential for the evaluation of IFRT as a treatment option for localised ITLPDGL, complete remission after relatively low-dose IFRT is promising, particularly as this has been rarely achieved by chemotherapy.
Identifiants
pubmed: 32224564
doi: 10.3960/jslrt.19022
pmc: PMC7187675
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7-10Références
Blood. 2011 Feb 3;117(5):1447-52
pubmed: 20966166
Blood. 2010 Dec 16;116(25):5631-7
pubmed: 20829373
J Clin Oncol. 2008 Sep 1;26(25):4124-30
pubmed: 18626005
Hematol Oncol. 2017 Mar;35(1):3-16
pubmed: 27353398
Blood. 2013 Nov 21;122(22):3599-606
pubmed: 24009234
Blood. 2016 May 19;127(20):2375-90
pubmed: 26980727
Br J Haematol. 2013 Apr;161(2):214-23
pubmed: 23432459
Hum Pathol. 2013 Sep;44(9):1927-36
pubmed: 23706909
Blood. 2004 Apr 1;103(7):2474-9
pubmed: 14645001
Blood. 2018 May 17;131(20):2262-2266
pubmed: 29592893